DIFFUSION-WEIGHTED IMAGING FOR DIFFERENTIATING MALIGNANT FROM BENIGN MEDIASTINAL LYMPHADENOPATHY

Introduction. Mediastinal lymphadenopathy can be caused by a wide range of benign and malignant states. Determination of the genesis of lymphadenopathy is crucial for treatment planning and prognosis of the disease.
The purpose of the study was to evaluate the diagnostic accuracy of diffusion weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurements in differentiating malignant versus benign mediastinal lymphadenopathy.
Material and Methods. 48 consecutive patients with at least one enlarged mediastinal lymph node revealed on CT-scans were examined on 1,5 T MR-machine with conventional images and respiratory-triggered DWI. In all patients one of the biggest solid lymph nodes was selected for ADC measurements and mean ADCs of each node were recorded. ADCs were correlated with the results of complete diagnostic work-up (including histopathological diagnosis in 41 patients) and follow-up CT. Statistics included Student’s t-test, Mann-Whitney U-test and ROC-curve analysis.
Results. 27 lymph nodes were classified as malignant (metastases, lymphoma) and 21 lymph nodes were classified as benign (sarcoidosis, reactive hyperplasia, tuberculosis). Mean ADC of malignant lymph nodes (1,02 ± 0,29×10−3 mm2/s) was significantly lower than that of benign lymph nodes (1,57 ± 0,32×10−3 mm2/s), p<0,0001. The cut-off value of ≤1,3×10−3mm2/s for ADC indicated the malignancy with a sensitivity of 81,5 % and a specificity of 85,7%. The area under the ROC-curve was 0,89 (95 % confidence interval: 0,77, 0,96), p<0,0001.
Conclusion. DWI is a promising technique in chest pathology. DWI with ADC measurements could be used as a good complementary tool in the diagnostic work-up of patients with mediastinal lymphadenopathy.

1. Potanin A.V., Vizel I.Yu., Potanin V.P., Vizel A.A. Invasive diagnosis at intrathoracic syndromes of lymphadenopathy and disseminations. The Bulletin of Contemporary Clinical Medicine. 2011; 4(3): 56a–60. (in Russian). doi: 10.20969/vskm.2011.4(3).56-60.

2. Stigt J.A., Boers J.E., Oostdijk A.H., van den Berg J.W., Groen H.J. Mediastinal incidentalomas. J Thorac Oncol. 2011 Aug; 6(8): 1345–9. doi: 10.1097/JTO.0b013e31821d41c8.

3. Munden R.F., Carter B.W., Chiles C., MacMahon H., Black W.C., Ko J.P., McAdams H.P., Rossi S.E., Leung A.N., Boiselle P.M., Kent M.S., Brown K., Dyer D.S., Hartman T.E., Goodman E.M., Naidich D.P., Kazerooni E.A., Berland L.L., Pandharipande P.V. Managing Incidental Findings on Thoracic CT: Mediastinal and Cardiovascular Findings. A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018 Aug; 15(8): 1087–1096. doi: 10.1016/j.jacr.2018.04.029.

4. Evison M., Crosbie P.A., Morris J., Martin J., Barber P.V., Booton R. A study of patients with isolated mediastinal and hilar lymphadenopathy undergoing EBUS-TBNA. BMJ Open Respir Res. 2014 May 31; 1(1): e000040. doi: 10.1136/bmjresp-2014-000040.

5. Nin C.S., de Souza V.V., do Amaral R.H., Schuhmacher N.R., Alves G.R., Marchiori E., Irion K.L., Balbinot F., Meirelles G.S., Santana P., Gomes A.C., Hochhegger B. Thoracic lymphadenopathy in benign diseases: A state of the art review. Respir Med. 2016 Mar; 112: 10–7. doi: 10.1016/j.rmed.2016.01.021.

6. de Langen A.J., Raijmakers P., Riphagen I., Paul M.A., Hoekstra O.S. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg. 2006 Jan; 29(1): 26–9. doi: 10.1016/j.ejcts.2005.10.002.

7. Wang H., Li Q.K., Auster M., Gong G. PET and CT features differentiating infectious/inflammatory from malignant mediastinal lymphadenopathy: A correlated study with endobronchial ultrasound-guided transbronchial needle aspiration. Radiol Infect Dis. 2018; 5(1): 7–13. doi: 10.1016/j.jrid.2018.01.002.

8. Chernov V.I., Dudnikova E.A., Goldberg V.E., Kravchuk T.L., Danilova A.V., Zelchan R.V., Medvedeva A.A., Sinilkin I.G., Bragina O.D., Popova N.O., Goldberg A.V. Positron Emission Tomography in the Diagnosis and Monitoring of Lymphomas. Medical Radiology and Radiation Safety. 2018; 63(6): 41–50. (in Russian). doi: 10.12737/article_5c0b8d 72a8bb98.40545646.

9. Chanchikova N.G., Dudnikova E.A., Karlova E.A., Savelyeva A.S., Silkina O.A., Zelchan R.V., Sinilkin I.G., Bragina O.D., Medvedeva A.A., Chernov V.I. Possibilities of 18F-FDG PET/CT in the diagnosis and staging of lymphomas. Problems in Oncology. 2019; 65(1): 147–153. (in Russian).

10. Chernov V.I., Dudnikova E.A., Goldberg V.E., Kravchuk T.L., Danilova A.V., Zelchan R.V., Medvedeva A.A., Sinilkin I.G., Bragina O.D., Belevich Yu.V., Koroleva E.S. Single-photon emission computed tomography in the diagnosis and monitoring of lymphoproliferative diseases. Medical Radiology and Radiation Safety. 2019; 64(3): 58–63. (in Russian). doi: 10.12737/article_5cf3dfefe60b13.90120976.

11. Chernov V.I., Dudnikova E.A., Zelchan R.V., Kravchuk T.L., Danilova A.V., Medvedeva A.A., Sinilkin I.G., Bragina O.D., Goldberg V.E., Goldberg A.V., Frolova I.G. The first experience of using 99mtc-1-thio-d-glucose for single-photon emission computed tomography imaging of lymphomas. Siberian Journal of Oncology. 2018; 17(4): 81–87. (in Russian). doi: 10.21294/1814-4861-2018-17-4-81-87.

12. Malayeri A.A., El Khouli R.H., Zaheer A., Jacobs M.A., Corona-Villalobos C.P., Kamel I.R., Macura K.J. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics. 2011 Oct; 31(6): 1773–91. doi: 10.1148/rg.316115515.

13. Bonekamp S., Corona-Villalobos C.P., Kamel I.R. Oncologic applications of diffusion-weighted MRI in the body. J Magn Reson Imaging. 2012 Feb; 35(2): 257–79. doi: 10.1002/jmri.22786.

14. Luna A., Sánchez-Gonzalez J., Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am. 2011 Feb; 19(1): 69–94. doi: 10.1016/j.mric.2010.09.006.

15. Herneth A.M., Mayerhoefer M., Schernthaner R., Ba-Ssalamah A., Czerny Ch., Fruehwald-Pallamar J. Diffusion weighted imaging: lymph nodes. Eur J Radiol. 2010 Dec; 76(3): 398–406. doi: 10.1016/j. ejrad.2010.08.016.

16. Razek A.A., Elkammary S., Elmorsy A.S., Elshafey M., Elhadedy T. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging. 2011 Feb; 29(2): 167–72. doi: 10.1016/j. mri.2010.08.002.

17. Razek A.A., Gaballa G., Elashry R., Elkhamary S. Diffusionweighted MR imaging of mediastinal lymphadenopathy in children. Jpn J Radiol. 2015 Aug; 33(8): 449–54. doi: 10.1007/s11604-015-0434-1.

18. Ustabasioglu F.E., Samanci C., Alis D., Samanci N.S., Kula O., Olgun D.C. Apparent Diffusion Coefficient Measurement in Mediastinal Lymphadenopathies: Differentiation between Benign and Malignant Lesions. J Clin Imaging Sci. 2017 Mar 6; 7: 12. doi: 10.4103/jcis. JCIS_84_16.

19. Gümüştaş S., Inan N., Sarisoy H.T., Anik Y., Arslan A., Ciftçi E., Akansel G., Demirci A. Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol. 2011 Nov; 21(11): 2255–60. doi: 10.1007/s00330-011-2180-9.

20. Sun M., Cheng J., Zhang Y., Bai J., Wang F., Meng Y., Li Z. Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index. Eur Radiol. 2018; 28(4): 1701–1708. doi: 10.1007/s00330-017-5135-y.

21. Prabhakar H.B., Rabinowitz C.B., Gibbons F.K., O’Donnell W.J., Shepard J.A., Aquino S.L. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT. AJR. 2008 Mar; 190(3 Suppl): S16. doi: 10.2214/AJR.07.7001.